ADIENT ($ADNT) posted quarterly earnings results for Q2 2026 on Wednesday, May 6th. The company reported earnings of $0.52 per share, beating estimates of $0.44 by $0.08. The company also reported revenue of $3,865,000,000, beating estimates of $3,701,560,732 by $163,439,268.
You can see Quiver Quantitative's $ADNT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ADIENT Insider Trading Activity
ADIENT insiders have traded $ADNT stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ADNT stock by insiders over the last 6 months:
- MICHEL PIERRE ROSE BERTHELIN (EVP, EMEA) sold 2,500 shares for an estimated $49,275
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
ADIENT Hedge Fund Activity
We have seen 110 institutional investors add shares of ADIENT stock to their portfolio, and 151 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 3,376,583 shares (-67.7%) from their portfolio in Q4 2025, for an estimated $64,729,096
- BLACKROCK, INC. removed 1,108,258 shares (-7.5%) from their portfolio in Q4 2025, for an estimated $21,245,305
- LYRICAL ASSET MANAGEMENT LP removed 1,009,685 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $19,355,661
- WOODLINE PARTNERS LP added 814,761 shares (+113.7%) to their portfolio in Q4 2025, for an estimated $15,618,968
- ROYAL BANK OF CANADA removed 722,429 shares (-99.1%) from their portfolio in Q4 2025, for an estimated $13,848,963
- TWO SIGMA INVESTMENTS, LP added 597,849 shares (+359.4%) to their portfolio in Q4 2025, for an estimated $11,460,765
- QUBE RESEARCH & TECHNOLOGIES LTD added 510,807 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,792,170
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
ADIENT Analyst Ratings
Wall Street analysts have issued reports on $ADNT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/12/2026
To track analyst ratings and price targets for ADIENT, check out Quiver Quantitative's $ADNT forecast page.
ADIENT Price Targets
Multiple analysts have issued price targets for $ADNT recently. We have seen 8 analysts offer price targets for $ADNT in the last 6 months, with a median target of $26.0.
Here are some recent targets:
- Ryan Brinkman from JP Morgan set a target price of $26.0 on 04/23/2026
- Michael Ward from Citigroup set a target price of $33.0 on 04/15/2026
- Nathan Janes from Stifel set a target price of $26.0 on 04/14/2026
- Colin Langan from Wells Fargo set a target price of $28.0 on 03/31/2026
- Dan Levy from Barclays set a target price of $26.0 on 03/30/2026
- Andrew Percoco from Morgan Stanley set a target price of $22.0 on 02/05/2026
- Joseph Spak from UBS set a target price of $32.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
